Sleep Medications Associated With Chances of Dementia
SAN FRANCISCO (Dispatches) -- New research indicates that sleep medications increase the risk of dementia in whites. However, the type and quantity of the medication may be factors in explaining the higher risk.
Researchers from the University of California studied approximately 3,000 older adults without dementia, who lived outside of nursing homes, were enrolled in the Health, Aging and Body Composition study and followed over an average duration of nine years. Their average age was 74; 42% were Black and 58% were white.
During the study, 20% developed dementia. White participants who “often” or “almost always” took sleep medications had a 79% higher chance of developing dementia compared to those who “never” or “rarely” used them. Among Black participants -- whose consumption of sleep aids was markedly lower -- frequent users had a similar likelihood of developing dementia than those who abstained or rarely used the medications.
The researchers found that whites, at 7.7%, were three times as likely as Blacks, at 2.7%, to take sleep medications often, five to 15 times a month, or almost always, 16 times a month to daily. Whites were almost twice as likely to use benzodiazepines, like Halcion, Dalmane and Restoril, prescribed for chronic insomnia.